Kirkland & Ellis Represents Madison Dearborn, Ikaria in $2.3B Sale to Mallinckrodt

Kirkland & Ellis LLP represented Madison Dearborn Partners and Ikaria, Inc., a privately held critical care company, which today announced that it has reached a definitive agreement with Mallinckrodt plc under which a subsidiary of Mallinckrodt will acquire Ikaria from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion. Mallinckrodt (NYSE: MNK), is a leading global specialty biopharmaceutical company. Subject to customary closing conditions, the parties expect the transaction to be completed early in the second calendar quarter of 2015. 

More >>

Milbank Advises AWAS on US$4 Billion Sale of a Portfolio of 90 Aircraft to Macquarie Group Limited

Milbank, Tweed, Hadley & McCloy have advised Dublin-based aircraft lessor, AWAS and its owners Terra Firma and Canada Pension Plan Investment Board (“CPPIB”) on an agreement to sell a portfolio of 90 aircraft to Macquarie Group Limited (ASX; MQG; ADR: MQBKY) for a total consideration of US$4 billion. The sale is expected to close within 12 months and is subject to customary closing conditions.

More >>

Cahill Represents Initial Purchasers in $925 Million Notes Offering by Digicel

Cahill represented Citigroup, J.P. Morgan, Barclays, Credit Suisse, and Deutsche Bank Securities as joint book-running managers in connection with the Rule 144A offering of $925,000,000 aggregate principal amount of 6.75% Senior Notes due 2023 by Digicel Limited, a leading provider of wireless communications services in the Caribbean region. Proceeds from the offering were used to refinance existing indebtedness and for general corporate purposes. Cahill is also representing Citigroup Global Markets as dealer manager in connection with the concurrent tender offer of any and all of Digicel’s outstanding 8.250% Senior Notes due 2017.

Johnson & Johnson’s Offer from Cardinal Health to Acquire Cordis for $1.99 Billion

Johnson & Johnson announced a binding offer from Cardinal Health to acquire its Cordis business for an aggregate value of $1.99 billion, consisting of $1.944 billion of cash proceeds from Cardinal Health plus approximately $46 million of retained net receivables. Cravath is representing Johnson & Johnson in connection with this transaction. The acceptance period for the offer will end on May 30, 2015, unless extended. If the offer is accepted, the proposed transaction would be expected to close towards the end of 2015, subject to customary closing conditions and regulatory approvals.

More >>

Shearman & Sterling Advises Underwriters in Ford Motor Credit Company’s $2.0 Billion Notes Offering

Shearman & Sterling represented Barclays Capital Inc., Credit Agricole Securities (USA) Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC and RBC Capital Markets, LLC as joint book-running managers and Banco Bradesco BBI S.A., BB Securities Limited, Lloyds Securities Inc., Mizuho Securities USA Inc. and SG Americas Securities, LLC as co-managers in connection with Ford Motor Credit Company LLC’s offering of $500,000,000 aggregate principal amount of its Floating Rate Notes due January 9, 2018, $750,000,000 aggregate principal amount of 2.145% Notes due January 9, 2018 and $750,000,000 aggregate principal amount of 3.219% Notes due January 9, 2022.

More >>

Leading Patent Attorney Jeffrey Lewis Joins Fried Frank’s Intellectual Property Litigation Practice

Fried, Frank, Harris, Shriver & Jacobson LLP announced today that Jeffrey I.D. Lewis has joined the Firm as a partner in the Intellectual Property Litigation Practice, resident in the New York office. Mr. Lewis concentrates on patent litigation and also handles trademark matters, as well as other intellectual property and general litigation. A trained chemical engineer and registered patent attorney, Mr. Lewis represents both plaintiffs and defendants in a range of technology-related sectors but focuses primarily on pharmaceuticals, chemicals, biotechnology and life sciences; he has represented pharmaceutical innovators in numerous Abbreviated New Drug Application (ANDA) patent litigations.

More >>

Constangy, Brooks & Smith Adds Don Prophete as Named Partner

Labor and employment law firm Constangy, Brooks & Smith, LLP announced today that nationally-recognized attorney Donald Prophete is joining the firm which will now be known as Constangy, Brooks, Smith & Prophete, LLP.

Eleven other attorneys from across the country are also joining the firm, which will add offices in Denver and New York to its 25 current locations. The new attorneys come to the firm with a wide range of backgrounds and are part of a concerted effort by Constangy to remain well-positioned to represent employers in the challenges they face in a more tech-savvy, diverse workplace environment.

More >>

Willkie Advises GFI Group in $778 million Sale to BGC Partners

GFI Group Inc. and BGC Partners, Inc. announced on February 27 the successful completion of BGC’s tender offer for GFI shares. Willkie advised GFI Group in an agreement announced earlier this month with BGC Partners under which GFI’s board of directors unanimously agreed to support BGC’s tender offer for all of the outstanding shares of GFI common stock at $6.10 per share in cash. The deal is estimated to be valued at approximately $778 million. The agreement brings to a close a long, protracted takeover battle that began last summer.

More >>